Pre‑treatment evaluation, diagnostic testing, and PAP documentation required

An evaluation and diagnosis must occur with a qualified physician or an Advanced Practice Provider working under the direct supervision of a physician prior to beginning treatment; diagnostic confirmation with polysomnography or HSAT is required where specified. When alternative therapies are proposed, documentation that PAP therapy resulted in no therapeutic efficacy or that the individual is intolerant or has refused PAP (including attempts to improve adherence) must be included.

• In-person or telemedicine evaluation by a qualified physician or APP under direct physician supervision required before treatment.
• Sleep study documentation (PSG or HSAT) required where specified in coverage criteria.
• Documented PAP failure, intolerance, or refusal (with adherence attempts) required for consideration of alternatives.

Implantable neurostimulator device and lead codes listed — prior authorization likely

Implantable neurostimulator devices and related implantable leads/pulse generators are listed in the applicable codes (e.g., L8679, L8680, L8686) and associated implant interrogation/programming CPT codes are provided; inclusion implies these implantable neurostimulation services may require prior authorization per plan/contract.

• Billing codes listed include L8679, L8680, L8686 and CPT codes for phrenic nerve stimulator interrogation/programming (e.g., 93150–93153).
• Listing of a code does not guarantee coverage; prior authorization may be required per federal, state, or contractual rules.

Prescribe custom, titratable oral appliance and arrange follow‑up

When oral appliance therapy (OAT) is prescribed for OSA, a qualified dentist should provide a custom, titratable appliance and the sleep physician should arrange follow-up testing and periodic visits to confirm efficacy and monitor dental side effects.

• Use a custom, titratable oral appliance (HCPCS E0486 applies to custom fabricated devices).
• Sleep physician should order follow-up sleep testing and coordinate periodic visits with a qualified dentist.

Document medical diagnosis, dentist collaboration, and PAP failure/intolerance

Ensure the medical provider documents the OSA diagnosis and refers/collaborates with a qualified dentist for oral appliance therapy; when OAT is used as an alternative to PAP, include documentation of PAP failure, intolerance, or refusal.

• Medical provider must diagnose OSA and document referral to a qualified dentist (AADSM guidance).
• When OAT replaces PAP, include explicit documentation that PAP failed, was not therapeutically effective, or was not tolerated/refused.

Prior authorization expected for implantable neurostimulation procedures

Surgical implantation of implantable neurostimulation devices (phrenic nerve stimulation and hypoglossal nerve stimulation) is described in trials and device labeling; prior authorization is expected to confirm clinical eligibility and required pre‑implant documentation.

• Remedē (phrenic nerve stimulator) and hypoglossal nerve stimulation devices are discussed with trial-based evidence; plan review and prior authorization are implied.
• Pre-implant objective sleep metrics and documentation of prior therapies will be required to support medical necessity.

Authorize tongue/hyoid procedures only with PSG baseline and CPAP failure documentation

Prior authorization for tongue and hyoid procedures should include objective baseline testing (PSG/AHI) and documentation of CPAP failure/intolerance when the surgery is intended for CPAP‑intolerant patients; clear surgical indication (e.g., DISE-confirmed tongue obstruction) should be documented.

• Require preoperative PSG or HSAT results documenting AHI and relevant anatomic findings.
• Document CPAP failure/intolerance/refusal when surgery is proposed as a CPAP alternative and include DISE findings when indicated.

Document prior therapies and justify selection for surgical/device interventions

Procedures such as multilevel surgery, maxillomandibular advancement, radiofrequency ablation, and hypoglossal nerve stimulation require documentation of prior noninvasive therapies (e.g., PAP or oral appliance attempts) and justification for the selected intervention before authorization.

• Document prior attempts with guideline‑recommended therapies and that the patient is medically stable.
• Provide procedure‑specific selection rationale (anatomic indications, prior response to therapies).

Require prior authorization for devices with FDA‑specified indications (Inspire, remedē)

Prior authorization is expected when implanting devices that have specific FDA‑approved indications and patient‑selection criteria (for example Inspire UAS and remedē System) to confirm members meet labeled indications and payer criteria.

• Confirm device-specific FDA indication criteria (e.g., Inspire AHI/BMI and absence of complete concentric collapse; remedē labeling for CSA).
• Submit documentation that member meets device labeling and policy selection criteria for review.

Use updated CPT codes and include required documentation with prior authorization

Certain surgical and implantable device procedures have updated applicable CPT codes (CPT 64568 and 64569 added; CPT 42299 removed) and prior authorization requests should include documentation meeting policy diagnosis criteria and provider evaluation.

• Note CPT additions: 64568 and 64569; CPT 42299 removed from applicable codes list.
• Include evidence of pre-treatment evaluation by a qualified provider and that diagnosis thresholds (e.g., AHI/RDI) are met when submitting authorization.

Stepwise requirement: attempt PAP before oral appliance or surgery

Oral appliance therapy may be used when PAP therapy has failed, was not tolerated, or was refused; for many surgical options, meet the policy diagnosis thresholds (e.g., moderate-to-severe OSA) and document prior PAP attempts before advancing therapy.

• OAT requires documentation that PAP resulted in no therapeutic efficacy, intolerance, or refusal.
• Surgical options (e.g., UPPP, MMA) require diagnosis thresholds (AHI/RDI ≥ 15) and PAP failure/intolerance documentation.

Document treatment sequence and prior conservative therapy attempts

Maintain treatment sequence documentation: lifestyle modification and positional therapy, then PAP, then oral appliance therapy, followed by electrostimulation devices and surgical options; prior use or intolerance of less invasive therapies should be documented when requesting advanced interventions.

• Document trials of conservative therapies (weight loss, positional strategies) where used.
• Provide records of PAP and oral appliance attempts and outcomes before seeking device implantation or surgery.

Document CPAP trials or intolerance before alternate device therapies

Document CPAP trials or intolerance: CPAP is the recommended initial therapy and is more effective than positional techniques; providers should document attempts with CPAP or reasons for intolerance when proposing alternate device therapies.

• Include CPAP trial data and adherence or efficacy information in the medical record.
• If EPAP/Provent or positional devices are proposed, document why CPAP was not used or tolerated.

CPAP recommended first-line; document when alternatives are used

CPAP is recommended as initial therapy for OSA; oral appliances, myofunctional therapy, positional therapy, or surgery are typically considered when CPAP is not tolerated or is ineffective and this should be documented.

• Ensure documentation shows CPAP was attempted unless contraindicated.
• Provide rationale for selecting non‑CPAP therapies when CPAP is not feasible.

Expect evidence of prior guideline therapies and medical stability for device authorization

Studies and device trials required prior guideline‑recommended therapies and clinical stability before enrollment; prior authorization reviews should mirror these expectations by requiring documentation of prior noninvasive therapy attempts.

• Submit evidence of prior guideline‑recommended therapy attempts and clinical stability where relevant to device candidacy.
• Follow study/device preselection testing timelines (e.g., recent PSG within 6 months where required).

Document attempts at conservative therapy before surgery

Non‑surgical therapies (for example CPAP) and conservative options should be documented as attempted or contraindicated prior to approving certain surgical interventions; provide objective pre‑ and post‑procedure sleep study results and rationale.

• Include pre- and post-procedure PSG/HSAT results, AHI and ESS scores, and oxygen saturation data when applicable.
• Document that noninvasive therapies were attempted and either failed, were not tolerated, or were contraindicated.

Require noninvasive therapy attempts before surgery per guideline recommendations

Attempt CPAP or oral appliance therapy before many surgical options per clinical guidelines; authorization for surgery should include documentation of prior noninvasive therapy attempts and procedure‑specific anatomic findings.

• Provide objective evidence of prior CPAP or OAT trials and outcomes.
• Document anatomical indications (e.g., craniofacial deformity for MMA) supporting the surgical choice.

Document prior PAP failure/intolerance and device selection criteria for Inspire UAS

For Inspire UAS (upper airway stimulation), patient selection requires prior failure or intolerance of positive airway pressure (PAP) therapies and consideration of AHI/BMI limits and absence of complete concentric collapse per FDA labeling; include documentation of these criteria in authorization requests.

• Confirm prior PAP failure/intolerance and submit PSG showing AHI within device‑specified range and BMI within limits.
• Provide DISE results demonstrating absence of complete concentric collapse when required.

Require documentation of PAP failure/intolerance before Oral Appliance Therapy

Oral Appliance Therapy may be considered when PAP has failed or the patient is intolerant; providers must document PAP failure/intolerance or refusal (including adherence efforts) before authorizing OAT for many indications.

• Include documentation that PAP produced no therapeutic efficacy or was not tolerated/refused.
• Attach objective sleep study results demonstrating OSA meeting diagnostic criteria.

Medical record must fully support medical necessity and contain diagnostic test results

The patient's medical record must include relevant medical history, physical examination, and results of pertinent diagnostic tests or procedures (e.g., PSG/HSAT, DISE) to support medical necessity; records must be legible and may be requested during review.

• Include sleep study reports, diagnostic test results, and clinical notes documenting symptoms and prior therapy attempts.
• Ensure documentation is complete and available upon request to avoid administrative denial.

Oral appliance coding note and dental service exclusion

Custom fabricated oral devices (HCPCS E0486) include fitting and adjustment; dental CDT codes are generally excluded from the medical plan—verify federal, state, or contractual rules before determining coverage.

• Use HCPCS E0486 for custom, titratable oral appliances (includes fitting and adjustment).
• Dental CDT codes (e.g., D9947–D9949) are generally excluded under the medical plan; check applicable contractual rules.

Document diagnosis, prescription, qualified‑dentist evaluation, and follow‑up for Oral Appliance Therapy

When oral appliance therapy is used for OSA, document a medical diagnosis by a medical provider, a sleep physician prescription for OAT, evidence of qualified‑dentist evaluation, and follow‑up testing and periodic dental and sleep‑medicine visits.

• Provide a sleep physician prescription and qualified dentist evaluation notes.
• Include follow-up sleep testing results and periodic dental/sleep‑medicine follow-up documentation.

Include pre‑implant PSG, DISE, and pre/postoperative sleep study results in documentation

Required clinical documentation for advanced therapies includes pre‑implant polysomnography (within six months if not already available), DISE results when applicable, pre‑ and post‑operative PSG or HSAT results, BMI and AHI values, and device‑specific eligibility criteria.

• Submit recent PSG (within 6 months) or HSAT, DISE findings to exclude contraindications (e.g., circumferential palatal collapse), and objective pre/post procedure sleep study results.
• Include patient selection data such as BMI, AHI, and device eligibility per FDA labeling.

Suggested documentation elements: indication, prior therapies, objective outcomes, and rationale

Documentation should include indication (e.g., CPAP intolerance or failure), prior noninvasive therapy attempts, objective pre‑ and post‑procedure testing (AHI, ESS, oxygen saturation), and rationale for selecting the surgical or device intervention given limited long‑term evidence.

• Provide indication, prior therapy history, objective outcome measures, and informed consent noting limited/insufficient long‑term evidence where applicable.
• Include rationale for selecting the intervention over alternative therapies.

Provide documentation that device implantation meets FDA‑indicated patient selection

Documentation must support that the implanted device matches FDA‑indicated use (for example remedē for moderate to severe CSA; Inspire for selected OSA patients meeting AHI/BMI and DISE criteria); prior authorization submissions should include evidence of meeting those FDA indications.

• Attach FDA‑relevant device labeling or references and objective patient data demonstrating compliance with labeled selection criteria.
• For pediatric Down syndrome indications, include age, AHI/RDI values, prior adenotonsillectomy status, and DISE findings per PMA expansion.

Ensure records show diagnosis thresholds and qualified pre‑treatment evaluation to avoid denial

Documentation must show the individual met diagnosis requirements (e.g., AHI or RDI ≥ 15 when applicable) and that evaluation occurred with a qualified physician or APP under direct physician supervision before treatment; lack of such documentation may lead to denial.

• Include PSG/HSAT demonstrating AHI/RDI meeting policy thresholds and records of pre‑treatment clinician evaluation.
• Failure to provide supporting medical records demonstrating medical necessity may result in denial.

Documentation must match FDA indications for implantable devices or risk denial

Documentation should support device use consistent with FDA indications (for example remedē for moderate to severe CSA; Inspire for selected OSA patients meeting AHI/BMI and DISE criteria); absence of evidence that the member meets FDA/device selection criteria may result in denial.

• Provide PSG/HSAT results, BMI, DISE findings, and prior therapy attempts to confirm device candidacy.
• Devices used outside FDA‑indicated patient selection may not meet coverage expectations.

Provide complete medical records on request; absence of documentation risks denial

Medical records must fully support medical necessity, including relevant medical history, physical exam, and diagnostic test results; records may be requested for review and failure to provide supporting documentation can result in denial—coverage is governed by federal, state, or contractual requirements.

• Ensure all requested records are legible and provided upon request during prior authorization or claims review.
• Remember that listing of a code in the policy does not guarantee coverage; benefit coverage is determined by applicable contractual and legal requirements.

Oral appliances for CSA unsupported—expect denials if used for CSA

Removable oral appliances are unsupported for the treatment of central sleep apnea; claims for OAT to treat CSA may be denied and providers should not submit oral appliance therapy requests for CSA without supportive evidence.

• No relevant evidence identified to support use of oral appliances for CSA.
• Claims for removable oral appliances to treat CSA may be denied.

Lack of prior therapy documentation or clinical stability may lead to denial

Before approving procedures or devices, reviewers expect prior noninvasive therapy attempts and justification; lack of documentation of prior PAP/oral appliance trials and medical stability may lead to denial or case‑by‑case review.

• Provide evidence of prior guideline‑recommended therapies and attempts to improve adherence.
• Include clinical stability information consistent with trial enrollment criteria where applicable.

Justify procedures with evidence of harm (e.g., LAUP) or risk denial

Procedures with evidence suggesting potential harm or unfavorable outcomes (for example LAUP, which has been associated with worsening AHI in some patients) require clear justification and supporting documentation; lack of justification may lead to denial.

• LAUP has shown a substantial proportion of patients with AHI worsening and should be justified with patient‑specific documentation if proposed.
• Provide risk/benefit discussion and objective data if proposing procedures with unfavorable evidence.

Evidence limitations for some procedures may trigger case‑by‑case review or denial

Devices and procedures lacking high‑quality comparative studies or long‑term outcomes (for example many tongue base and minimally invasive procedures) may be subject to denial or case‑by‑case review; provide robust documentation to support medical necessity.

• Include long‑term outcome data and comparative evidence when available; absence of such evidence increases likelihood of case‑by‑case review or denial.
• Attach published studies and rationale for selection when evidence is limited.